Le Lézard
Classified in: Health
Subject: FDA

Zeta Surgical's Mixed Reality Navigation System Receives FDA Special 510(k) Clearance for Expanded Functionality


BOSTON, Jan. 11, 2024 /PRNewswire/ -- Zeta Surgical, a surgical robotics and mixed reality company, announced today that its Zeta Cranial Navigation System has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded functionality through enhanced software features and compatibility with additional accessories.

The Zeta Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings. The platform received its first 510(k) clearance from the U.S. FDA in September 2023.

Dr. Roman Stolyarov, Chief Product Officer of Zeta Surgical, commented on the clearance: "This new FDA clearance enables key enhancements in usability and performance, bringing us closer to achieving our mission of dramatically reducing the barriers to surgical navigation and unlocking its benefits for a wider array of patients and procedures."

"We are thrilled to scale Zeta's deployments in the U.S., building on its early successes in clinics," said Jose Amich, Co-Founder and CEO of Zeta Surgical. "We look forward to seeing Zeta's impact on patient outcomes and in the field of neuroscience."

About Zeta Surgical

Zeta Surgical is a digital surgery company focused on improving the accuracy, safety, and accessibility of image guided procedures. Its navigation and robotics platform leverages cutting-edge computer vision and artificial intelligence to enable surgical guidance directly at the point-of-care, democratizing care by creating new possibilities in fields such as emergency care, interventional medicine, and drug delivery.  Zeta Surgical was founded by Harvard graduates and faculty and is backed by leading investors. To learn more, visit: www.zetasurgical.com.

Contact:
Jose Amich
jose.amich@zetasurgical.com

SOURCE Zeta Surgical


These press releases may also interest you

at 10:30
Flourishing Foundations Recovery has launched a new outpatient detox center in San Antonio, TX, aiming to help individuals tackle drug and alcohol addiction without pausing their daily lives. The new substance abuse treatment center ensures easy...

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: